• Stop Clopez Corp voluntarily recalls herbal dietary supplement

    April 26, 2024 - On April 23, 2024, the United States FDA published a voluntary recall from Stop Clopex Corp regarding its Schwinnng capsules. According to the recall, the product was found to contain Nortadalafil, an active drug ingredient, during an FDA analysis. Dietary supplements are only loosely regulated across the United States. Unlike pharmaceutical...

  • CDC, FDA investigate harmful counterfeit Botox

    April 19, 2024 - On April 15, 2024, the United States Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) launched an investigation into harmful reactions caused by counterfeit or mishandled botulinum toxin (Botox). According to a CDC outbreak investigation report, as of April 12, 2024, 19 reported illnesses caused by Botox...

  • CRN launches new labeling guidelines for melatonin supplements

    April 17, 2024 - On April 15, 2024, the Council for Responsible Nutrition (CRN), one of the most prominent trade associations for the dietary supplements industry, issued a statement highlighting new labeling guidelines for all gummy supplements, specifically melatonin gummy supplements. Melatonin supplements have recently been critiqued for a lack of regulation...

  • Abbott provided $650,000 to FDA advisory panel members

    April 11, 2024 - How should regulatory bodies and consumers weigh payments made by life sciences companies to FDA advisory panel members? That’s the question posed by the recent news that 10 of 14 voting members on the United States FDA advisory board for the Abbott TriClip G4 System received payments from Abbott between 2016 and 2022. Based on their...


Today's Top Stories

Stop Clopez Corp voluntarily recalls herbal dietary supplement

On April 23, 2024, the United States FDA published a voluntary recall from Stop Clopex Corp regarding its Schwinnng capsules. According to the recall, the product was found to contain Nortadalafil, an...

Metformin use is associated with reduced cancer risk

Two recent studies published in the Journal of the National Cancer Institute have correlated metformin use with lower cancer risks, implying that the drug may offer some protection against the...

NIH researchers develop AI tool for personalized oncology

On April 18, 2024, researchers from the National Institutes of Health (NIH) published a proof-of-concept study in Nature Cancer detailing a new artificial intelligence (AI) tool to match patients with...

CDC, FDA investigate harmful counterfeit Botox

On April 15, 2024, the United States Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) launched an investigation into harmful reactions caused by counterfeit or...

CRN launches new labeling guidelines for melatonin supplements

On April 15, 2024, the Council for Responsible Nutrition (CRN), one of the most prominent trade associations for the dietary supplements industry, issued a statement highlighting new labeling...

EPA finalizes chemical plant clean air standards

On April 9, 2024, the United States Environmental Protection Agency (EPA) finalized a ruling to regulate toxic air pollution from chemical plants. The finalized ruling focuses on two primary...

DMARDs for rheumatoid arthritis linked to lower dementia risk

Research published in Rheumatic & Musculoskeletal Disease found that patients with rheumatoid arthritis (RA) who were taking biological disease-modifying antirheumatic drugs (DMARDs) had a 24%...

View all stories